For example, in various cancers, the PI3K-AKT-mTOR pathway is activated and frequently upregulated because of biallelic loss of PTEN, activating mutations in AKT1 and PIK3CA/B, and overexpression of certain growth factors.29 This evidence concerns the gene MTOR and cancer.